Medicinal chemistry – Page 62
-
News
NIH wants scientists to consider sex in research
Preclinical and clinical research is overreliant on male test subjects which can cloud future work in humans
-
FeatureFaster, cheaper, better diagnostics
Microfluidics researchers are aiming to bring new diagnostic devices into mainstream medicine. Mark Peplow reports
-
Business
Review says cheaper drug is safe for eye disease
Cochrane collaboration says side effects of expensive Lucentis and off-label Avastin are similar
-
FeatureChemistry in bloom
Sarah Houlton discovers the chemistry among the specimens at many botanical gardens
-
ResearchPainkiller found in plants may not be natural after all
Cow pats from cattle fed tramadol could explain how the drug came to be in an African herb
-
ResearchCoated nanoparticles show Alzheimer's promise
Gold nanoparticles functionalised with amino acid polymer inhibit the growth of amyloid fibres associated with neurodegenerative disease
-
ResearchAntimalarial flow synthesis closer to commercialisation
Scientists in Germany hope their continuous flow method will boost accessibility of artemisinin-derived medicines
-
ResearchCPU heat powers PCR disease detection
Computer and mobile phone combo detects Chagas disease in blood and could drive down diagnosis costs
-
ResearchHigher levels of some metals in e-cigarette smoke
Scientists call for regulators to help clear smoke and mirrors surrounding vaping safety
-
ResearchBringing chemical synthesis to the masses
Researchers hope simple system to build thousands of peptides without enzymes, cells or reagents will be accessible to all
-
PodcastChemistry World podcast - September 2014
We speak to Paul Clarke about the challenges of natural product synthesis and discuss the pros and cons of perovskite solar cells
-
Business
Servier to appear in adverts over lack of transparency
Adverts in the medical press will name French pharma firm for failing to comply with disclosure rules
-
ResearchUrine test could catch lung cancer early
Cancer diagnosis could be accelerated using an approach that is low cost, rapid and non-invasive
-
Business
Piramal exits drug discovery in India
Company will concentrate on generic medicines and clinical and contract research.
-
ResearchExperimental Ebola drug 'impressive' in animal trials
All primates given ZMapp are cured of Ebola but the drug is still a long way from approval in humans
-
Research
Ionic liquids join battle against antibiotic resistance
Organic salts disrupt biofilms to leave resistant bacteria at the mercy of antibiotics
-
ResearchFluorinating new life into an increasingly ineffective antibiotic
Aminoglycoside analogue evades bacterial resistance mechanism
-
-
ResearchYeast turned into morphine and opioid biofactories
Scientists hope that biotech route could protect the drug supply chain from harvest failures and problems with illicit use
-
NewsDoctors turn to experimental Ebola treatments
Drugs and vaccines untested in humans are being trialled on Ebola patients